Welcome to epgonline.org - the website for healthcare professionals

What's new?

  • ,

    Launch of Obesity Learning Hub

    A learning hub has recently launched on epgonline.org offering comprehensive
    information on obesity. Healthcare professionals now have free access to the
    Knowledge Centre, EACCME-accredited European Obesity Initiative CME series
    and a range of additional resources including events information, news and
    journal articles, a clinical media library and patient guides.

  • ,

    Anti-Infectives Knowledge Network (AIKN) IFI
    Updates

    Latest update: a report has been added to the congresses section from the ‘Integrating
    Critical Care and Haemato-oncology’ meeting held in Berlin, November 2014. Experts
    gathered to share opinion and debate on the changing nature of care for haemato-oncology
    patients requiring critical care. The report is available to view free of charge.

    August 2015 MYC/15/0023/EUa

  • ,

    Summer updates to Anti-Infectives Knowledge
    Network – CDI

    New content has been added to the Anti-Infectives Knowledge Network – Clostridium difficile
    infection (AIKN-CDI). The congresses section has been updated to include reports on
    important sessions from ECCMID 2015 and CDI data presented at the 5th International
    Clostridium difficile Symposium (ICDS) 2015 held in Bled, Slovenia on 19-21 May. An
    article titled ‘Antimicrobial Espionage’ has also been added to the CDI perspectives section.

  • ,Whats new CLL KC

    Launch of Chronic Lymphocytic Leukaemia (CLL)
    Knowledge Centre

    The new CLL Knowledge Centre contains useful resources for healthcare professionals
    treating this condition. There are three key areas: ‘Disease awareness’ (epidemiology,
    pathophysiology, diagnosis and treatment), ‘Events’ (upcoming meetings and congresses)
    and ‘Resources’ (links to useful sites and organisations).

  • ,Whats New CSU

    Launch of Chronic Spontaneous Urticaria (CSU)
    Knowledge Centre

    A new Chronic Spontaneous Urticaria (CSU) Knowledge Centre has
    launched on epgonline.org to raise awareness and improve early diagnosis
    of the condition. Healthcare professionals will have free access to a
    disease overview, recent symposia highlights, a video channel and useful resources.

Latest News

FDA approves supplemental NDA for Aptiom (eslicarbazepine acetate) monotherapy to treat partial onset seizures- Sunovion + Eisai

01-Sep-2015

Sunovion Pharma announced that the FDA approved the supplemental NDA for Aptiom (eslicarbazepine acetate) monotherapy for the treatment of partial onset seizures. This new approval allows Aptiom to be used as a monotherapy in people who initiate ...

FDA issues warning of severe joint pain relating to DPP-4 inhibitors

01-Sep-2015

The FDA has issued a warning to healthcare providers and patients about concerns over severe and disabling joint pain associated with DPP-4 inhibitors following a search of the FDA adverse event reporting system and published literature. The warning ...

Swiss approval for Cotellic (cobimetinib) + Zelboraf (vemurafenib) to treat advanced melanoma- Roche

01-Sep-2015

Exelixis announced that Swissmedic, the medical licensing and supervisory authority of Switzerland, has approved cobimetinib for use in combination with vemurafenib as a treatment for patients with advanced melanoma. Cobimetinib is a selective ...

InSite Vision files NDA for BromSite (0.075% bromfenac) treatment of inflammation and prevention of ocular pain following post-cataract surgery

01-Sep-2015

InSite Vision Inc, a company developing ophthalmic products for unmet eye care needs, announced that the FDA has accepted for review InSite’s New Drug Application (NDA) for BromSite (0.075% bromfenac). The FDA has assigned a Prescription Drug ...

LPCN 1021 filed with FDA for hypogonadism- Lipocine

01-Sep-2015

Lipocine Inc has submitted a New Drug Application to the FDA for LPCN 1021, an oral testosterone product candidate for testosterone replacement therapy (TRT) in adult males for conditions associated with a deficiency or absence of endogenous ...

HDM-SLIT (house dust mite sublingual allergy immunotherapy tablet) approved in the EU for allergic rhinitis and allergic asthma- ALK

01-Sep-2015

ALK has obtained European approval for its HDM-SLIT (house dust mite sublingual allergy immunotherapy tablet) against allergic rhinitis and allergic asthma. The HDM SLIT-tablet is indicated in adult patients (18–65 years) diagnosed by a ...

Phase III trial of Dysport (abobotulinumtoxinA) in brain injury patients with spasticity published in The Lancet Neurology- Ipsen

01-Sep-2015

Ipsen announced that The Lancet Neurology has published clinical trial results showing the efficacy and safety of Dysport (abobotulinumtoxinA) in post-stroke or traumatic brain injury patients with upper limb spasticity. The international Phase III ...

Recent Updates

Drugs

Clinical Guidelines

Prostate Cancer: ESMO Clinical Practice Guidelines

European Stroke Organisation (ESO) guidelines for the management of temperature in patients with acute ischemic stroke

Anaemia management in people with chronic kidney disease

Lower urinary tract symptoms: The management of lower urinary tract symptoms in men

Medical Journals

Transcutaneous supraorbital neurostimulation in "de novo" patients with migraine without aura: the first Italian experience.

Orlistat limits cholesterol intestinal absorption by Niemann-pick C1-like 1 (NPC1L1) inhibition.

Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker

A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells.

epgonline.org Social

Disease Topics

Disease Topics

48 Disease areas packed with insight

Disease Topics

Knowledge Centres

Diagnosis, patient management, treatment strategies & decision support

Drug Database

Drug Database

Summary information on thousands of prescription drugs available in 9 languages

News

News

News written for doctors around pharmacological development

Treatment Guidelines

Clinical Guidelines

Professional association and governmental guidance on treatment

Disease Topics

Clinical Trials

Medical research & drug development - current and past landmark studies

Medical Journals

Medical Journals

Journal articles, titles and extracts from respected publishers

Disease Topics

Medical Apps

All the latest free and paid-for Apps selected for doctors